MBX Capital LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
MBX Capital LLC
CRD #312079
SEC #802-132412
CIK #0001844430
AUM
Employees
Phone646-389-3388
Address12 Ridge Road
Tuxedo Park, NY 10987
Source [IAPD] [EDGAR] [Website] [Twitter]
Total AUM ($)
1.00.80.60.40.20.02010201520212027
Type Form D Funds Date Sold AUM
VC Capsule 17 A Series of MBX Capital Opportunities I LLC [2026-03-09] 0.4 M 0.4 M
Offered $400,000 · Filed 2025-02-13 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $25,000 · Duration One year or less · Net Assets Decline to Disclose
VC Capsule 18 A Series of MBX Capital Opportunities I LLC [2026-03-09] 0.7 M 0.7 M
Offered $695,000 · Filed 2025-05-08 (D) · Exemption 506(b), 3(c), 3(c)(1) · Duration One year or less · Net Assets Decline to Disclose
VC Capsule 19 A Series of MBX Capital Opportunities I LLC [2026-03-09] 0.3 M 0.3 M
Offered $275,000 · Filed 2025-08-26 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $25,000 · Duration One year or less · Net Assets Decline to Disclose
VC MBX Capital NYS Ssbci Fund LP [2025-03-21] 5.8 M
Offered $6,000,000 · Filed 2025-03-13 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining $6,000,000 · Duration One year or less · Revenue Decline to Disclose
VC Atlas Health Capsule A Series of Fundrx Master Fund I LLC [2025-03-14] 0.2 M 1.8 M
Offered $155,000 · Filed 2019-07-24 (D) · Exemption 506(b), 3(c)(1) · Minimum $5,000 · Duration One year or less · Net Assets Decline to Disclose
VC Capsule 10 A Series of MBX Capital Opportunities I LLC [2025-03-14] 0.6 M 0.6 M
Offered $618,130 · Filed 2022-06-03 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $25,000 · Duration One year or less · Net Assets Decline to Disclose
VC Capsule 11 A Series of MBX Capital Opportunities I LLC [2025-03-14] 0.1 M 0.1 M
Offered $122,000 · Filed 2023-09-08 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $25,000 · Duration One year or less · Net Assets Decline to Disclose
VC Capsule 12 A Series of MBX Capital Opportunities I LLC [2025-03-14] 0.7 M 1.2 M
Offered $705,500 · Filed 2024-03-06 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $25,000 · Duration One year or less · Net Assets Decline to Disclose
VC Capsule 13 A Series of MBX Capital Opportunities I LLC [2025-03-14] 0.1 M 0.1 M
Offered $105,000 · Filed 2023-08-31 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $25,000 · Duration One year or less · Net Assets Decline to Disclose
VC Capsule 14 A Series of MBX Capital Opportunities I LLC [2025-03-14] 0.2 M 0.2 M
Offered $220,000 · Filed 2024-07-05 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $10,000 · Duration One year or less · Net Assets Decline to Disclose
VC Capsule 15 A Series of MBX Capital Opportunities I LLC [2025-03-14] 0.3 M 0.3 M
Offered $319,990 · Filed 2024-05-14 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $10,000 · Duration One year or less · Net Assets Decline to Disclose
VC Capsule 16 A Series of MBX Capital Opportunities I LLC [2025-03-14] 0.3 M 0.3 M
Offered $300,600 · Filed 2024-08-21 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $25,000 · Duration One year or less · Net Assets Decline to Disclose
VC Capsule 6 A Series of MBX Capital Opportunities I LLC [2025-03-14] 1.1 M 1.1 M
Offered $1,146,603 · Filed 2022-01-10 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $1,603 · Duration One year or less · Revenue Decline to Disclose
VC Capsule 7 A Series of MBX Capital Opportunities I LLC [2025-03-14] 2.9 M 2.9 M
Offered $2,927,532 · Filed 2022-02-02 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $2,500 · Duration One year or less · Revenue Decline to Disclose
VC Capsule 8 A Series of MBX Capital Opportunities I LLC [2025-03-14] 1.0 M 4.0 M
Offered $1,010,000 · Filed 2022-02-02 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $10,000 · Duration One year or less · Revenue Decline to Disclose
VC Capsule 9 A Series of MBX Capital Opportunities I LLC [2025-03-14] 1.2 M
Offered $1,161,703 · Filed 2022-03-23 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $10,000 · Duration One year or less · Revenue Decline to Disclose
VC Capsule Fund 15 A Series of Fundrx Master Fund I LLC [2025-03-14] 0.1 M 0.1 M
Offered $80,000 · Filed 2017-11-15 (D) · Exemption 506(b), 3(c)(1) · Minimum $15,000 · Duration One year or less · Net Assets Decline to Disclose
VC Capsule Fund 16 A Series of Fundrx Master Fund I LLC [2025-03-14] 0.1 M
Offered $110,000 · Filed 2017-08-24 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $25,000 · Duration One year or less · Net Assets Decline to Disclose
VC Carerev Capsule A Series of Fundrx Master Fund I LLC [2025-03-14] 0.1 M
Offered $130,000 · Filed 2019-07-29 (D) · Exemption 506(b), 3(c)(1) · Minimum $5,000 · Duration One year or less · Net Assets Decline to Disclose
VC Cloudcath Capsule A Series of Fundrx Master Fund I LLC [2025-03-14] 0.1 M 0.1 M
Offered $130,000 · Filed 2019-12-17 (D) · Exemption 506(b), 3(c)(1) · Minimum $5,000 · Duration One year or less · Net Assets Decline to Disclose
VC Concert Health Capsule A Series of Fundrx Master Fund I LLC [2025-03-14] 0.1 M 0.2 M
Offered $59,000 · Filed 2019-03-27 (D) · Exemption 506(b), 3(c)(1) · Minimum $5,000 · Duration One year or less · Net Assets Decline to Disclose
VC Contraline Capsule A Series of Fundrx Master Fund I LLC [2025-03-14] 0.3 M 0.3 M
Offered $290,000 · Filed 2020-05-05 (D) · Exemption 506(b), 3(c)(1) · Minimum $5,000 · Duration One year or less · Net Assets Decline to Disclose
VC Fundrx Capsule 13 A Series of Fundrx Master Fund I LLC [2025-03-14] 0.1 M
Offered $130,000 · Filed 2017-08-10 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $15,000 · Duration One year or less · Net Assets Decline to Disclose
VC Fundrx Capsule 14 A Series of Fundrx Master Fund I LLC [2025-03-14] 0.1 M 0.3 M
Offered $55,640 · Filed 2017-07-20 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $15,000 · Duration One year or less · Net Assets Decline to Disclose
VC Fundrx Capsule 18 A Series of Fundrx Master Fund I LLC [2025-03-14] 0.1 M
Offered $130,000 · Filed 2017-11-08 (D) · Exemption 506(b), 3(c)(1) · Minimum $15,000 · Duration One year or less · Net Assets Decline to Disclose
VC Fundrx Capsule 19 A Series of Fundrx Master Fund I LLC [2025-03-14] 0.1 M 0.4 M
Offered $70,000 · Filed 2018-04-26 (D) · Exemption 506(b), 3(c)(1) · Duration One year or less · Net Assets Decline to Disclose
VC Fundrx Capsule 20 A Series of Fundrx Master Fund I LLC [2025-03-14] 0.1 M 0.1 M
Offered $100,000 · Filed 2017-12-06 (D) · Exemption 506(b), 3(c)(1) · Minimum $20,000 · Duration One year or less · Net Assets Decline to Disclose
VC Fundrx Capsule 21 A Series of Fundrx Master Fund I LLC [2025-03-14] 0.1 M 0.0 M
Offered $55,000 · Filed 2017-12-14 (D) · Exemption 506(b), 3(c)(1) · Minimum $20,000 · Duration One year or less · Net Assets Decline to Disclose
VC Fundrx Capsule 22 A Series of Fundrx Master Fund I LLC [2025-03-14] 0.2 M
Offered $165,000 · Filed 2018-03-28 (D) · Exemption 506(b), 3(c)(1) · Minimum $20,000 · Duration One year or less · Net Assets Decline to Disclose
VC Fundrx Capsule 23 A Series of Fundrx Master Fund I LLC [2025-03-14] 0.1 M 0.2 M
Offered $125,000 · Filed 2018-08-02 (D) · Exemption 506(b), 3(c)(1) · Minimum $20,000 · Duration One year or less · Net Assets Decline to Disclose
VC Fundrx Capsule 25 A Series of Fundrx Master Fund I LLC [2025-03-14] 0.1 M
Offered $90,000 · Filed 2018-07-11 (D) · Exemption 506(b), 3(c)(1) · Minimum $20,000 · Duration One year or less · Net Assets Decline to Disclose
VC Fundrx Capsule 31 A Series of Fund RX Master Fund I LLC [2025-03-14] 0.1 M 0.1 M
Offered $108,480 · Filed 2018-07-11 (D) · Exemption 506(b), 3(c)(1) · Minimum $20,000 · Duration One year or less · Net Assets Decline to Disclose
PE Fundrx Capsule 32 A Series of Fundrx Master Fund I LLC [2025-03-14] 0.7 M 1.9 M
Offered $660,000 · Filed 2020-01-28 (D) · Exemption 506(b), 3(c)(1) · Minimum $5,000 · Duration One year or less · Net Assets Decline to Disclose
VC MBX Capital II-A LP [2025-03-14] 4.5 M 4.0 M
Offered $4,493,000 · Filed 2023-03-29 (D) · Exemption 506(b), 3(c), 3(c)(1) · Duration One year or less · Revenue Decline to Disclose
VC MBX Capital III-A LP [2025-03-14] 1.4 M 1.4 M
Offered $1,445,000 · Filed 2025-03-11 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose
VC MBX Capital III LP [2025-03-14] 29.3 M
Offered $50,000,000 · Filed 2023-08-09 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining $50,000,000 · Duration One year or less · Revenue Decline to Disclose
VC MBX Capital II LP [2025-03-14] 24.6 M
Offered $30,000,000 · Filed 2021-01-11 (D) · Exemption 506(b), 3(c), 3(c)(1) · Remaining $30,000,000 · Duration One year or less · Revenue Decline to Disclose
VC MBX Capsule 1 A Series of MBX Capital Opportunities 2020 LLC [2025-03-14] 0.2 M
Offered $245,000 · Filed 2020-12-29 (D) · Exemption 506(b), 3(c)(1) · Minimum $10,000 · Duration One year or less · Net Assets Decline to Disclose
VC MBX Capsule 2 A Series of MBX Capital Opportunities 2021 LLC [2025-03-14] 0.2 M 0.2 M
Offered $225,000 · Filed 2021-05-20 (D) · Exemption 506(b), 3(c)(1) · Minimum $5,000 · Duration One year or less · Net Assets Decline to Disclose
VC MBX Capsule 3 A Series of MBX Capital Opportunities 2021 LLC [2025-03-14] 0.1 M 0.1 M
Offered $98,000 · Filed 2021-05-11 (D) · Exemption 506(b), 3(c)(1) · Minimum $10,000 · Duration One year or less · Net Assets Decline to Disclose
VC MBX Capsule 4 A Series of MBX Capital Opportunities 2021 LLC [2025-03-14] 0.1 M 0.1 M
Offered $130,000 · Filed 2021-08-17 (D) · Exemption 506(b), 3(c)(1) · Minimum $10,000 · Duration One year or less · Net Assets Decline to Disclose
VC Neuromotion Capsule A Series of Fundrx Master Fund I LLC [2025-03-14] 0.1 M 0.1 M
Offered $95,000 · Filed 2019-05-15 (D) · Exemption 506(b), 3(c)(1) · Minimum $5,000 · Duration One year or less · Net Assets Decline to Disclose
VC FRX Select I LP [2019-03-28] 13.5 M
Offered $25,000,000 · Filed 2018-11-08 (D) · Exemption 506(b), 3(c), 3(c)(1) · Remaining $25,000,000 · Duration One year or less · Revenue Decline to Disclose
VC FRX Sensulin LLC [2017-03-31] 0.0 M
Offered $40,000 · Filed 2017-03-15 (D) · Exemption 506(b), 3(c), 3(c)(1) · Duration One year or less · Net Assets Decline to Disclose
VC Fundrx Epibone Fund A Series of Fundrx Master Fund I LLC [2017-03-31] 0.1 M
Offered $70,000 · Filed 2016-12-01 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $20,000 · Duration One year or less · Net Assets Decline to Disclose
VC Fundrx Soundbite Fund A Series of Fundrx Master Fund I LLC [2017-03-31] 0.1 M
Offered $85,000 · Filed 2016-07-22 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $5,000 · Duration One year or less · Net Assets Decline to Disclose
AUM Breakdown Accounts AUM ($)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 0 0.0
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 0 0.0
By Discretionary
Discretionary 0 0.0
Non-Discretionary 0 0.0
Total 0 0.0
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 0.0
Total 0 0.0
Form D Directors Role # Filings # Firms 2011 - 2026
Richard Thoms Executive Officer 7187 139
Assure Fund Management II Director, Executive Officer 6187 139
Jeremy Neilson Executive Officer 6656 98
Allocations Fund Administration Executive Officer 718 22
Mateo Johnson Executive Officer 622 21
Erin Rosenthal Executive Officer 329 21
Hoang Phan Executive Officer 446 20
Jens Beyrich Executive Officer 905 19
Gurdane Bhutani Director, Executive Officer 16 2
Zeshan Muhammedi Director 9 2
View All
EDGAR Form CIK 2011 - 2026
SC 13G [0001844430]
Form 13D/13G Filer Form 13D/13G Subject Filed
MBX Capital LLC Gray Television Inc [2021-07-20]
Firm Profile (Form ADV)
Fund TypesPrivate Equity
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com